Massachusetts Eye and Ear

Last updated
Massachusetts Eye and Ear
Massachusetts Eye and Ear Hospital logo.svg
Mass-Eye-and-Ear.jpg
MEE Main Campus
Massachusetts Eye and Ear
Geography
Location243 Charles Street, Boston, Massachusetts, United States
Coordinates 42°21′38.39″N71°04′12.09″W / 42.3606639°N 71.0700250°W / 42.3606639; -71.0700250
Organization
Type Specialist
Affiliated university Harvard Medical School
Services
Emergency department 24-hour emergency ophthalmology and otolaryngology service
Beds41 [1]
Speciality Ophthalmology, Otolaryngology
History
Opened1824 [2]
Links
Website www.masseyeandear.org
Lists Hospitals in Massachusetts

Massachusetts Eye and Ear (Mass. Eye and Ear, or MEE) is a specialty hospital located in Boston, Massachusetts, United States, which focuses on ophthalmology (eye), otolaryngology (ear/nose/throat), and related medicine and research. Founded in 1824 as the Boston Eye Infirmary (BEI), it has also been known as the Massachusetts Charitable Eye and Ear Infirmary (MCEEI), and Massachusetts Eye and Ear Infirmary (MEEI). [2] It is a teaching partner of Harvard Medical School.

Contents

Massachusetts Eye and Ear has earned an international reputation for its successful treatment of the most difficult diseases and conditions of the eye, ear, nose, throat, head, and neck, and for its outstanding contributions to medical research and education. In 2018, Massachusetts Eye and Ear has two adult specialties nationally ranked the "U.S. News Best Hospitals Rankings and Ratings 2018-18, with the Department of Ophthalmology ranked number four in the U.S. and the Department of Otolaryngology placing number six in the nation. [3]

The primary teaching hospital for Harvard Medical School in ophthalmology and otolaryngology, Massachusetts Eye and Ear trains more than 110 residents and fellows each year in its various sub-specialties, including cornea, neuro-ophthalmology, retina, eye pathology, pediatrics, glaucoma, ocular oncology, immunology, head & neck surgery, oncology, pediatric otolaryngology, facial plastics, otology and oto-neurology. [2] In addition to ophthalmology and otolarynology, the hospital provides patient services and conducts research and clinical training in audiology (diagnostics, hearing aids and cochlear implants), balance (vestibular), facial nerve, thyroid, voice and speech, and vision rehabilitation.

Main campus

The hospital's main campus is located in Boston's West End, surrounded by various Massachusetts General Hospital (MGH) buildings. MEEI and MGH are both Harvard Medical School teaching hospitals, the MGH departments of Otolaryngology and Ophthalmology are actually departments at MEEI, [4] [5] and both hospitals tend to refer patients to one another. Despite this organizational and physical closeness, MEEI is a separate organization from MGH, with its own Board of Directors and executive team. Notwithstanding this distinction, maps will often show the entire area labeled as "Massachusetts General Hospital".[ citation needed ]

Consisting of a 12-story tower, the current main building was completed in 1973. [6] It houses 42 inpatient beds. [1]

The transit stop serving the two hospitals is "Charles/MGH" on the MBTA Red Line train. The signs at the train station (which was rebuilt and opened in 2007) have smaller printing reading "Mass. Eye and Ear Infirmary" in addition to the prominent "Charles/MGH" signs. C. Stephen Foster developed the first ocular immunology service at Massachusetts Eye and Ear Infirmary. [7] [8]

The main campus is also home to the Norman Knight Hyperbaric Medicine Center, which provides 24-hour emergency treatment for smoke inhalation, carbon monoxide poisoning, and diving injuries such as decompression sickness ("the bends"). Treatment for problem-wound healing is also conducted in the center. [9]

History

In a notice published on April 2, 2018, Massachusetts Eye and Ear's President John Fernandez announced the finalization of the agreement to make MEE a part of the Mass General Brigham hospital and physicians network. [10]

In April 2021, the organization settled a lawsuit over improper Medicare and Medicaid billing for $2.7 million. [11]

Other locations

Massachusetts Eye and Ear has a total of 18 sites in the Greater Boston region, including locations in the Longwood Medical Area, Joslin Diabetes Center in Boston, and Braintree, Concord, Duxbury, East Bridgewater, Milton, Medford, Newton, Plainville, Providence RI, Quincy, Stoneham, Waltham, Weymouth. [12]

Related Research Articles

<span class="mw-page-title-main">Ophthalmology</span> Field of medicine treating eye disorders

Ophthalmology is a surgical subspecialty within medicine that deals with the diagnosis and treatment of eye disorders. A former term is oculism.

<span class="mw-page-title-main">Massachusetts General Hospital</span> Hospital in Massachusetts, United States

Massachusetts General Hospital is the original and largest teaching hospital of Harvard Medical School, Harvard University located in the West End neighborhood of Boston, Massachusetts. Massachusetts General Hospital houses the world's largest hospital-based research program, the Mass General Research Institute, with an annual research budget of more than $1.2 billion in 2021. It is the third-oldest general hospital in the United States with a patient capacity of 999 beds. Along with Brigham and Women's Hospital, Mass General is a founding member of Mass General Brigham, formerly known as Partners HealthCare, the largest healthcare provider in Massachusetts. It is currently ranked among the best hospitals in the United States by U.S. News & World Report.

<span class="mw-page-title-main">Mass General Brigham</span> Health care system based in Greater Boston, Massachusetts

Mass General Brigham is a not-for-profit, integrated health care system that is a national leader in medical research, teaching, and patient care. It is the largest hospital-based research enterprise in the United States, with annual funding of more than $2 billion. The system's annual revenue was nearly $18 billion in 2022. It is also an educational institution, founded by Brigham and Women's Hospital and Massachusetts General Hospital. The system provides clinical care through two academic hospitals, three specialty hospitals, seven community hospitals, home care services, a health insurance plan, and a robust network of specialty practices, urgent care facilities, and outpatient clinics/surgical centers. It is the largest private employer in Massachusetts. In 2023, the system reported that from 2017–2021 its overall economic impact was $53.4 billion – more than the annual state budget.

<span class="mw-page-title-main">New York Eye and Ear Infirmary</span> Hospital in New York, United States

New York Eye and Ear Infirmary of Mount Sinai (NYEE) is located at East 14th Street and Second Avenue in lower Manhattan, New York City. Founded on August 14, 1820, NYEE is America's first specialty hospital and one of the most prominent in the fields of ophthalmology and otolaryngology in the world, providing primary inpatient and outpatient care in those specialties. Previously affiliated with New York Medical College, as of 2013 it is affiliated with the Icahn School of Medicine at Mount Sinai as a part of the membership in the Mount Sinai Health System.

The Illinois Eye & Ear Infirmary (IEEI) is a center of ophthalmology and otolaryngology research and clinical practice.

Paul T. Finger, MD, FACS, is an ophthalmologist in New York, New York, specializing in ocular oncology. Finger is a Clinical Professor of Ophthalmology at the New York University School of Medicine in New York City, New York. He is also the director of The New York Eye Cancer Center and Ocular Tumor Services at The New York Eye and Ear Infirmary of Mt. Sinai. He consults for Northwell Health Complex of affiliated Hospitals including Manhattan Eye, Ear and Throat Hospital and NYU School of Medicine. He is Chair of the Ophthalmic Oncology Task Force for the American Joint Committee on Cancer (AJCC), wrote the eye cancer staging systems section for the Union International for Cancer Control (UICC). As Chair, he brought together an OOTF to develop consensus eye plaque radiation guidelines for The American Brachytherapy Society - American Association of Physicists in Medicine. Dr. Finger was the first the only ophthalmologist asked to serve on the 2012 American Association of Physicists in Medicine’s Task Group-129 that produced both dosimetry and quality assurance standards for plaque brachytherapy. As of 2021, Dr. Finger has authored over 335 peer-review scientific articles, 2 books, 54 book chapters and 2 web sites.

<span class="mw-page-title-main">University of Illinois Hospital & Health Sciences System</span> Hospital in IL, United States

The University of Illinois Hospital & Health Sciences System is a member of the Illinois Medical District, one of the largest urban healthcare, educational, research, and technology districts in the USA. The University of Illinois Hospital & Health Sciences System itself is composed of the 485-bed University of Illinois Hospital, outpatient diagnostic and specialty clinics, and two Federally Qualified Health Centers (FQHCs) that serve as primary teaching facilities for the University of Illinois at Chicago (UIC) Health Science Colleges. The eight-story inpatient facility provides patient care services from primary care through and including transplantation, with a medical staff in a variety of specialties. In 1999, the 245,000-square-foot (22,800 m2) Outpatient Care Center (OCC) opened with a fully computerized medical record system, allowing patient records to be accessible electronically. The OCC houses all subspecialty and general medicine outpatient services and the Women's Health Center.

The ÇOMÜ Hospital is the biggest research and teaching hospital in the Western Marmara region of Turkey which serves the area of north Aegean and South-West Marmara regions. The current president and chief executive officer is Dr. Murat Coşar. The hospital is a 160-bed facility that provides patients with a complete range of primary and specialty care services.

The American Osteopathic Boards of Ophthalmology and Otolaryngology - Head and Neck Surgery (AOBOO) is a joint organization that provides board certification to qualified Doctors of Osteopathic Medicine (D.O.) who specialize in the medical and surgical treatment of the eye (ophthalmologists) and to qualified Doctors of Osteopathic Medicine who specialize in the medical and surgical treatment of the ears, nose, and throat (otolaryngologists). The boards belong to the 18 medical specialty certifying boards approved by the American Osteopathic Association Bureau of Osteopathic Specialists of the American Osteopathic Association. As of December 2011, 736 osteopathic ophthalmologists and otolaryngologists held active certification with the AOBOO.

<span class="mw-page-title-main">Reza Dana</span> American ophthalmologist and immunologist

Reza Dana is the Claes H. Dohlman Professor of Ophthalmology, senior scientist and W. Clement Stone Clinical Research Scholar at Massachusetts Eye and Ear, Harvard Medical School, and director of the Harvard-Vision Clinical Scientist Development Program.

<span class="mw-page-title-main">Eugene Nicholas Myers</span>

Eugene Nicholas Myers is an oncologist and otolaryngologist and a leader in the treatment of head and neck cancer. He has served on the faculty of the University of Pittsburgh School of Medicine since 1972, when he became chairman of the Department of Otolaryngology. He is the author or co-author of leading texts in the field of head and neck cancer, and has chaired and served on the boards of the preeminent societies and associations in the field.

<span class="mw-page-title-main">Royal Victorian Eye and Ear Hospital</span> Hospital in Victoria, Australia

TheRoyal Victorian Eye and Ear Hospital is a specialist public teaching hospital in East Melbourne, Australia. It is the only hospital in Australia which specialises in both ophthalmology and otolaryngology.

Perry Rosenthal, was a Canadian-born American eye surgeon and professor of ophthalmology, known for his work in the development of the first gas-permeable scleral contact lens.

Joan Whitten Miller is a Canadian-American ophthalmologist and scientist who has made notable contributions to the treatment and understanding of eye disorders. She is credited for developing photodynamic therapy (PDT) with verteporfin (Visudyne), the first pharmacologic therapy for retinal disease. She also co-discovered the role of vascular endothelial growth factor (VEGF) in eye disease and demonstrated the therapeutic potential of VEGF inhibitors, forming the scientific basis of anti-VEGF therapy for age-related macular degeneration (AMD), diabetic retinopathy, and related conditions.

Charles Stephen Foster is an American ophthalmologist known for his research and treatment of ocular inflammatory disease (OID) with immunomodulatory therapy. In addition, Foster is the author of approximately 1,000 papers and 14 textbooks. His focus tends to be dedicated to the advancement of ophthalmology. Foster established the Ocular Immunology and Uveitis Foundation to support relevant research. He is currently is a mentor and part-time professor of ophthalmology at Harvard Medical School.

<span class="mw-page-title-main">V. S. Sangwan</span> Indian ophthalmologist

Virender Singh Sangwan is an Indian ophthalmologist and the Dr. Paul Dubord Chair professor and director of the L. V. Prasad Eye Institute, Hyderabad. Known for his research on limbal stem cells, Sangwan is the founder secretary and an adviser of the Uveitis Society of India. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards for his contributions to Medical Sciences in 2006.

Santosh Gajanan Honavar is an Indian ophthalmologist and is currently the Honorary General Secretary of the All India Ophthalmological Society; Director of Medical Services ; Director, Department of Ocular Oncology and Oculoplasty at Centre for Sight, Hyderabad; and Director, National Retinoblastoma Foundation. He was the Editor of the Indian Journal of Ophthalmology and Indian Journal of Ophthalmology - Case Reports, the official journals of the All India Ophthalmological Society from 2017 to 2023.

<span class="mw-page-title-main">Daniel M. Albert</span> American ophthalmologist, ocular cancer researcher and medical historian

Daniel M. Albert is an American ophthalmologist, ocular cancer researcher, medical historian, and collector of rare books and ocular equipment. As of 2018, he is Professor of Ophthalmology at the Casey Eye Institute, Oregon Health & Science University.

<span class="mw-page-title-main">John Jeffries II</span> American ophthalmic surgeon

John Jeffries II was an American ophthalmic surgeon who co-founded the Massachusetts Charitable Eye and Ear Infirmary in 1824 with Edward Reynolds. This organization, which began life as the Boston Eye Infirmary, became officially incorporated in 1826 and maintained that name until 1924 when it became Massachusetts Eye and Ear. Jeffries and Reynolds were the only surgical staff until 1833 when the staff was expanded to include other assistant surgeons as well as an apothecary. Jeffries resigned from this position in 1842 and had no other official interaction with the institution until his son Benjamin was named Surgeon of the Infirmary in 1867.

References

  1. 1 2 "Quick Facts about Mass. Eye and Ear". Mass. Eye and Ear. Retrieved 2015-12-15.
  2. 1 2 3 "History of Mass. Eye and Ear". Mass. Eye and Ear. Retrieved 2015-12-15.
  3. "Massachusetts Eye and Ear Infirmary". U.S. News & World Report . Retrieved 2018-08-14.
  4. "Ophthalmology". Massachusetts General Hospital. Retrieved 2015-12-15.
  5. "The Department of Otolaryngology (ENT)". Massachusetts General Hospital. Retrieved 2015-12-15.
  6. "Massachusetts Eye and Ear Infirmary". Emporis.com. Emporis GmbH. Archived from the original on April 29, 2014. Retrieved 2015-12-15.
  7. Network, International Scleroderma (31 December 2018). "ISN: Dr. C. Stephen Foster". Sclero.org. Retrieved 21 May 2019.
  8. "Sirion Therapeutics Acquires U S License To Develop New Treatment For Viral Eye Infection". Biospace.com.
  9. "Hyperbaric Medicine". Mass. Eye & Ear. Retrieved 2015-12-15.
  10. "Massachusetts Eye and Ear Joins Partners HealthCare". 2018-04-02. Retrieved 2018-04-02.
  11. "Mass. Eye And Ear Agrees To Pay $2.7M To Resolve Fraud Complaint". The Associated Press. 21 Apr 2021.
  12. "Massachusetts Eye and Ear Locations". Massachusetts Eye and Ear. Retrieved 2015-12-15.